Olivier Lantrès | Fieldfisher
Skip to main content
Professional background

Professional background

I am an expert on regulatory issues in the life sciences and healthcare sectors, in particular concerning medical devices, pharmaceutical and phytopharmaceutical products and cosmetics.

My main area of practice involves matters relating to advertising of pharmaceutical products, relationships with healthcare practitioners, clinical trials, and advising clients in the context of monitoring by the health authorities.

I am a Doctor of Law (magna cum laude) and ranked as a 'Leading Individual' by Legal 500 (2022) as well as Band 1 in Chambers 2022. In addition to this, I am also recognised and ranked by a number of other directories including PLC Which Lawyer, Best Lawyers in France and Décideurs Stratégie Finance Droit.

I was awarded a first prize by the French Healthcare Law Association for my work and also am a member of the professional associations ACIP and AMIPS.

I joined Fieldfisher as a Partner in 2008 after having worked with Price Waterhouse Coopers and Proskauer Rose LLP.

In addition to my native French, I am fluent in English.

 

Awards & recognition

Awards & recognition

Client
We had the pleasure of working with Mila Kovalenko, who exhibits outstanding professionalism and thorough knowledge of her areas of practice.
Chambers & Partners 2022
He has extremely good knowledge of the healthcare sector. He is always available and is very efficient.
The Legal 500 EMEA 2022
Olivier Lantrès has solid experience and excellent knowledge of the health sector and the issues encountered by his clients. He is surrounded by a competent and very responsive team. He is always there and always finds relevant and business-oriented solutions for his clients. Olivier has an activity established at Fieldfisher for many years which allows him to work transversally with the other teams of the firm. He is very responsive and, with his team, produces quality work at ‘fair’ prices.

Authored pieces

All Resources
A digital abstract image featuring a glowing blue particle wave flowing through a dark background. Below the wave, a network of interconnected points and lines creates a web-like structure, also illuminated in blue, giving a sense of data transmission and connectivity.
Life Sciences
Press Release

Fieldfisher secures key regulatory victories for Philagro France and Suterra in market access disputes

28.03.2025
PARIS – European law firm Fieldfisher has successfully represented Philagro France and Suterra Europe Biocontrol S.L. in two separate legal challenges against Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (ANSES), securing significant rulings that uphold market access for essential phytopharmaceutical products in France. 
Learn more
A modern operating room filled with medical equipment. There's a surgical table in the center, surrounded by monitors, overhead lights, and various machines. The lighting is dim with a bluish hue, giving an ambient atmosphere.
Insight

French judges clarify the notion of medical devices

18.02.2025
Learn more
A close-up image of a pile of various pills and capsules. The capsules are predominantly in shades of blue, pink, white, and purple, while the pills are mostly white. The background is a plain, light surface.
Insight

The French drug agency today published 33 decisions imposing fines on pharmaceutical companies for alleged non-compliance with the French rules on safety stocks

24.09.2024
Learn more
A person in a lab coat is drawing a molecular structure on a chalkboard with chalk. The other hand is holding a molecular model. The chalkboard has various scientific notations and diagrams related to DNA under a blue light.
Life Sciences
Insight

Towards an additional risk of pharmaceutical shortages due to new elements surrounding China's anti-espionage law?

10.09.2024
Learn more
Insight

Sustainability: a new era in clinical trials

05.01.2024
As the global focus on environmental, social, and governance (ESG) issues intensifies, the life sciences industry is emerging as a beacon of positive change. Amidst the challenges, there is palpable optimism as pharmaceutical companies and the international organisations and regulatory bodies that support them take a leadership role in sustainable innovation.
Learn more

What others say…

Client
We had the pleasure of working with Mila Kovalenko, who exhibits outstanding professionalism and thorough knowledge of her areas of practice.
Chambers & Partners 2022
He has extremely good knowledge of the healthcare sector. He is always available and is very efficient.
The Legal 500 EMEA 2022
Olivier Lantrès has solid experience and excellent knowledge of the health sector and the issues encountered by his clients. He is surrounded by a competent and very responsive team. He is always there and always finds relevant and business-oriented solutions for his clients. Olivier has an activity established at Fieldfisher for many years which allows him to work transversally with the other teams of the firm. He is very responsive and, with his team, produces quality work at ‘fair’ prices.